Novo Nordisk's total assets for Q1 2026 were kr559.22B, an increase of 3.01% from the previous quarter. GB:0QIU total liabilities were kr356.16B for the fiscal quarter, a 2.09% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.